| abstract |
OF THE DISCLOSURE nThe present disclosure relates to nucleic acid vaccine compositions and methods for npreventing or treating pathological conditions, such as cancer or infectious disease. Further, nthe disclosure provides methods for more efficient production of antigens via mRNA ncontaining one or more non-conventional start codons to promote multiplex initiation of ntranslation in eukaryotic cells. n17980547_1 (GHMatters) P104161.AU.1 |